A Favorable Benefit-Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment, by Qin 2023;34(7-8):339-340; doi: 10.1089/hum.2023.028.

Hum Gene Ther. 2023 Jul;34(13-14):662. doi: 10.1089/hum.2023.028.correx. Epub 2023 May 8.

Abstract

摘要

相似文献

Hum Gene Ther. 2023 Jul;34(13-14):662. doi: 10.1089/hum.2023.028.correx. Epub 2023 May 8.

Hum Gene Ther. 2023 Apr;34(7-8):339-340. doi: 10.1089/hum.2023.028.

Hum Gene Ther. 2019 Sep;30(9):1176. doi: 10.1089/hum.2018.229.correx.

Hum Gene Ther. 2022 Aug;33(15-16):840. doi: 10.1089/hum.2020.053.correx.

Hum Gene Ther. 2024 Mar 25. doi: 10.1089/hum.2023.208.correx.

Hum Gene Ther. 2015 Nov;26(11):777. doi: 10.1089/hum.2015.064.cxn. Epub 2015 Oct 21.

Hum Gene Ther. 2022 Jun;33(11-12):683-687. doi: 10.1089/hum.2007.0142.correx. Epub 2022 May 31.

Hum Gene Ther. 2018 Mar;29(3):400. doi: 10.1089/hum.2017.228.correx.

Hum Gene Ther. 2023 May;34(9-10):471. doi: 10.1089/hum.2022.079.correx. Epub 2023 May 3.

Hum Gene Ther. 2023 Oct;34(19-20):1072. doi: 10.1089/hum.2022.079.correx2. Epub 2023 Aug 3.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。